For the Inventor, By the Inventor

Enter assignee name

Barcelona, Spain

Laboratorios Almirall, S.a.

Calculating rank

USPTO Granted Patents = 21

% Expired Patents = 76.2

CIPO Patents = 1

Trademarks = 2

Forward Citations = 60

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Vittorio Dal Piaz (4 out of 4 patents)

Bernat Vidal Juan (3 out of 9 patents)

Maria Prat Quinones (3 out of 22 patents)

4. Maria Antonia Buil Albero (3 out of 23 patents)

5. Silvia Fonquerna Pou (3 out of 11 patents)

6. Jordi Gracia Ferrer (3 out of 8 patents)

7. Nuria Aguilar Izquierdo (3 out of 4 patents)

8. Maria Paola Giovannoni (3 out of 3 patents)

9. Claudia Vergelli (3 out of 3 patents)

10. Carlos Puig Duran (2 out of 19 patents)

11. Wenceslao Lumeras Amador (2 out of 5 patents)

12. Juan Francisco Caturla Javaloyes (2 out of 5 patents)

13. Paul Robert Eastwood (2 out of 12 patents)

14. Eloisa Navarro Romero (2 out of 7 patents)

15. Aranzazu Cardus Figueras (2 out of 3 patents)

21 patents: Sort by Forward Citations

1. 8258308 - Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors (2012-09-04),

2. 8044205 - Process for manufacturing 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (2011-10-25),

3. 7960383 - [object Object] (2011-06-14),

4. 7906530 - 1,7-naphthyridine derivatives as p38 MAP kinase inhibitors (2011-03-15),

5. 7855202 - [object Object] (2010-12-21),

6. 7790728 - Pyrazine derivatives useful as adenosine receptor antagonists (2010-09-07),

7. 7718670 - Quinuclidine amide derivatives (2010-05-18),

8. 7662814 - 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors (2010-02-16),

9. 7622480 - Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents (2009-11-24),

10. 7582676 - 2-phenylpyran-4-one derivatives as selective COX-2 inhibitors (2009-09-01),

11. 7560471 - Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents (2009-07-14),

12. 7557212 - Tricyclic derivatives as LTD4 antagonists (2009-07-07),

13. 7511038 - Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors (2009-03-31),

14. 7504398 - Substituted-4-(pyrrolo pyrimidin-6-yl)benzenesulphonamide derivatives (2009-03-17),

15. 7491722 - Pyridazin-3(2H)-one derivatives (2009-02-17),

Company Overview

Laboratorios Almirall, S.A. is a global pharmaceutical company headquartered in Barcelona, Spain, specializing in the development and commercialization of innovative medicines. The company focuses on dermatology, respiratory, and autoimmune diseases, leveraging advanced research and technology to address unmet medical needs. Almirall is committed to enhancing patient outcomes through its robust pipeline of therapeutic solutions and strategic partnerships, aiming to expand its presence in international markets.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

21 Patents

#33 in Barcelona

#93 in Spain

#30,018 in the World

Barcelona, Spain

Laboratorios Almirall, S.a.

Forward Citations = 60

54 inventors:

Vittorio Dal Piaz (4 out of 4 patents)

Bernat Vidal Juan (3 out of 9 patents)

Maria Prat Quinones (3 out of 22 patents)

4. Maria Antonia Buil Albero (3 out of 23 patents)

5. Silvia Fonquerna Pou (3 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Laboratorios Almirall, S.a.. Retrieved from https://idiyas.com/company/laboratorios-almirall-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…